Imed Orphan SAS is a pharmaceutical company that specializes in providing orphan drugs and highly specific therapies for rare diseases in Latin America. They offer clinical studies, market research, and CRO services, focusing on niche pharmaceuticals for rare diseases. Imed Orphan SAS is dedicated to acquiring, developing, registering, and marketing high medical value specialty medicines. They have a network of partnerships with European and American pharmaceutical companies specialized in rare diseases and are actively involved in medical meetings for rare diseases.
Headquarters
Av Cr. 19 # 120 - 71 Of 214 B
Bogota D.C.; Bogota D.C;
Postal Code: 1012
Contact Details: Purchase the Imed Orphan Sas report to view the information.
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service